Application

19623656 · DOSING REGIMENS OF ANTI-CD38 ANTIBODIES FOR TREATMENT OF SUBJECTS WITH IMMUNE THROMBOCYTOPENIA

Filed 2026-09-11 · Pending The official file ↗ · Art unit · Takeda Pharmaceutical Company Limited · Morgan, Lewis & Bockius LLP (TAKEDA LEGACY)

Office actions

first was

RCEs

no appeal

To first action

n/a

to disposition n/a

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.